ResearchMoz

Fungemia Global Clinical Trials Review, H2, 2012

Publisher Name » GlobalData
Published Date » 2012-08-15
No. Of Pages » 63
Fungemia Global Clinical Trials Review, H2, 2012

GlobalData's clinical trial report, Fungemia Global Clinical Trials Review, H2, 2012" provides data on the Fungemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fungemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fungemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Fungemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Fungemia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Fungemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Fungemia 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Fungemia Therapeutics Clinical Trials 26
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Pfizer Inc. 28
Clinical Trial Overview of Pfizer Inc. 28
BIOWEST THERAPEUTICS Inc 29
Clinical Trial Overview of BIOWEST THERAPEUTICS Inc 29
Fovea Pharmaceuticals SA 30
Clinical Trial Overview of Fovea Pharmaceuticals SA 30
Astellas Pharma Inc. 31
Clinical Trial Overview of Astellas Pharma Inc. 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
University of Pittsburgh 32
Clinical Trial Overview of University of Pittsburgh 32
Taipei Medical University WanFang Hospital 33
Clinical Trial Overview of Taipei Medical University WanFang Hospital 33
Chinese PLA General Hospital 34
Clinical Trial Overview of Chinese PLA General Hospital 34
Peking University 35
Clinical Trial Overview of Peking University 35
Rennes University Hospital 36
Clinical Trial Overview of Rennes University Hospital 36
Rambam Health Care Campus 37
Clinical Trial Overview of Rambam Health Care Campus 37
The Medical University of Graz 38
Clinical Trial Overview of The Medical University of Graz 38
Five Key Clinical Profiles 39

Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 63

List of Tables


Fungemia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 6
Fungemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Fungemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Fungemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 9
Fungemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10
Fungemia Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Fungemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 12
Fungemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13
Fungemia Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Fungemia Therapeutics Clinical Trials, G7 Countries, 2012* 15
Fungemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Fungemia Therapeutics Clinical Trials, E7 Countries, 2012* 17
Fungemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Fungemia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Fungemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Fungemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Fungemia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22
Fungemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Fungemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Fungemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Fungemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 28
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOWEST THERAPEUTICS Inc, 2012* 29
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2012* 30
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012* 31
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 32
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2012* 33
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese PLA General Hospital, 2012* 34
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University, 2012* 35
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2012* 36
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2012* 37
Fungemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012* 38

List of Figures

List of Figures

Fungemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 6
Fungemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Fungemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Fungemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 9
Fungemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10
Fungemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11
Fungemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 13
Fungemia Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14
Fungemia Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Fungemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Fungemia Therapeutics Clinical Trials, E7 Countries (%), 2012* 17
Fungemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Fungemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Fungemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Fungemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Fungemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Fungemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Fungemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Fungemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
GlobalData Methodology 62

Upcoming Reports:

Merchant-Paid Rewards Market: Industry Analysis, Market Size, Share, Trends, Growth And Forecast, 2011 - 2018
By - Transparency Market Research
Debit card users are increasing in number as compared to credit card users. Use of debit card allows the consumers to save money for future use as they know how much money they have and how much money they have to spend. This trend leads to the growth of merchant paid reward programs. Credit cards do not give customers this privilege as they pay later for whatever they have purchased. Merchant-paid programs persuade customers to use their debit cards rather than credit cards or paper coupons. Merchant paid programs are gaining popularity in the market as it offers...
Agricultural Chemical Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Agricultural farming depends on the climate and the soil. Soil, if not suitable for farming, is made suitable by the addition of chemicals like pesticides and fertilizers etc. Addition of these chemicals is done through various techniques like ploughing etc. Agricultural chemicals are used for improving the quality of soil and to increase the yield of the crop. They have to be carefully used and should be added in appropriate quantities since their overuse can sometimes be harmful to farmers as well as to the soil. Asian countries like India and China have extensively used these...
Smart/Intelligent Sensor Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
A smart/intelligent sensor is a device, which acquires input in the form of physical, chemical or biological mode, converts the input into digital form and relays the output on a monitoring device. The smart/intelligent sensor market can be classified on the basis of the input it measures, as smart flow sensors, smart pressure sensors, smart temperature sensors, smart position sensors and smart load/force sensors. Classification is further possible on the basis of its application in automobiles, medical sector, industry, avionics, meteorology and aerospace. Geographically the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...